Ilex Drug Helps One Leukemia, Not Another-US Panel
234104
SILVER SPRING, Md.  - A panel of medical experts  on Wednesday recommended approval for Ilex Oncology Inc.'s new  drug Clolar for use against one type of leukemia but not  against another.
548970
A drug widely used to treat H.I.V. infection may also be effective in fighting cancer, a new study suggests, and a human trial of the medicine is already under way.
610002
Arsenic, commonly used as an effective pesticide should be used as a first-line treatment for a rare form of leukemia, according to researchers.
118432
The US Food and Drug Administration (FDA) has approved the Eli Lilly drug Alimta, for the treatment of advanced non-small cell lung cancer in previously treated patients.
434352
NEW YORK  - Children being treated for acute lymphoblastic leukemia (ALL) seem more able to deal with their treatment if their levels of antioxidants don&#39;t drop too much, new study findings suggest.
536259
Genzyme Corp.'s not-yet-completed $1 billion acquisition of Ilex Oncology Inc. appeared to pay off yesterday when an advisory committee to the Food and Drug Administration recommended the agency approve Ilex's experimental cancer treatment for children with certain types of leukemia.
6113
Researchers have made a breakthrough discovery by identifying a gene that is responsible for childhood leukemia and the effects of the mutated gene, called NOTCH1, they say, can be inhibited by a type of drug designed to treat Alzheimerâs disease.
246378
About half the patients with aggressive non-Hodgkin&#39;s lymphoma in the United States don&#39;t receive the recommended dose and schedule of chemotherapy, which reduces their
350952
Next-generation leukemia pills,  designed to help patients not cured by the successful drug  Gleevec, work even better than doctors had hoped, researchers  said on Sunday.
688289
The Food and Drug Administration approved Clolar, Genzyme Corp.'s new drug for patients under 21 with acute lymphocytic leukemia. An advisory panel on Dec. 1 recommended the drug be approved. Clolar was developed by Ilex Oncology Inc., the Texas firm Cambridge-based Genzyme acquired last week in a $1 billion stock transaction. The FDA panel recommended that more studies be done ...
384412
Bristol-Myers' blood cancer drug Sprycel may work faster than Novartis' Gleevec, the once-a-day pill that transformed the treatment of some kinds of leukemia, researchers said on Saturday.
535223
An experimental drug under development by Bristol-Myers Squibb is showing early promise in reversing the signs and symptoms of patients whose chronic myeloid leukemia failed to respond to Gleevec, which is considered the standard of treatment for the
1957
A drug currently used to treat kidney cancer has shown promising results in treating the most common and deadly form of adult leukemia, according to a US study released Tuesday.
416254
CAMBRIDGE, Massachusetts The drug Clolar has won Food and Drug Administration approval to treat patients ages one to 21 who have exhausted other treatment options for acute lymphoblastic leukemia.
343531
NEW YORK  - Children being treated for  acute lymphoblastic leukemia (ALL) seem more able to deal with  their treatment if their levels of antioxidants don't drop too  much, new study findings suggest.
205305
Federal health advisers on Wednesday recommended approval of the first new cancer drug in the past decade specifically aimed at treating the most common childhood leukemia.
186518
A proposed leukemia drug should not receive federal approval, government advisers recommended Wednesday.